TELA Bio Reports First Quarter 2022 Financial Results
May 10, 2022 16:01 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in Upcoming 2022 H.C. Wainwright Annual Global Investment Conference
May 09, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 29, 2022 17:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., April 29, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Announce First Quarter 2022 Financial Results
April 26, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Appoints D. Taylor Ocasio as General Counsel
April 18, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., April 18, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference
March 30, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results
March 21, 2022 16:01 ET
|
TELA Bio, Inc.
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL
March 16, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., March 16, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that...
TELA Bio to Announce Fourth Quarter and Full Year 2021 Financial Results
March 07, 2022 16:01 ET
|
TELA Bio, Inc.
MALVERN, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution
March 03, 2022 07:00 ET
|
TELA Bio, Inc.
MALVERN, Pa., March 03, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...